We are live on ! Find out more
AA

Apriem Advisors Portfolio holdings

AUM $1.05B
1-Year Est. Return 22.09%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+22.09%
3 Year Est. Return
+62.04%
5 Year Est. Return
+69.09%
10 Year Est. Return
+243.72%
AUM
$667M
AUM Growth
+$41.9M
Cap. Flow
+$7.26M
Cap. Flow %
1.09%
Top 10 Hldgs %
49.91%
Holding
154
New
3
Increased
48
Reduced
56
Closed
11

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$1.49M
2
TSLA icon
Tesla
TSLA
+$1.43M
3
MMM icon
3M
MMM
+$1.1M
4
CTAS icon
Cintas
CTAS
+$634K
5
SCHF icon
Schwab International Equity ETF
SCHF
+$529K

Sector Composition

Rank Sector Weight
1 Technology 18.94%
2 Industrials 9.23%
3 Healthcare 7.36%
4 Energy 4.89%
5 Consumer Discretionary 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHX icon
1
Schwab US Large- Cap ETF
SCHX
$70.7B
$89.8M 13.47%
5,146,365
+396,966
+8% +$6.55M
AAPL icon
2
Apple
AAPL
$5T
$50.4M 7.56%
259,827
-771
-0.3% -$134K
SCHF icon
3
Schwab International Equity ETF
SCHF
$64.9B
$34.5M 5.18%
1,938,264
-29,790
-2% -$529K
VGSH icon
4
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$29.9M 4.49%
518,515
-3,490
-0.7% -$203K
VEA icon
5
Vanguard FTSE Developed Markets ETF
VEA
$223B
$26.2M 3.93%
567,790
+35,664
+7% +$1.64M
SCHZ icon
6
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$24.8M 3.72%
1,075,028
-18,794
-2% -$437K
SNA icon
7
Snap-on
SNA
$21.4B
$24.6M 3.69%
85,436
-458
-0.5% -$119K
REGN icon
8
Regeneron Pharmaceuticals
REGN
$72.9B
$18.4M 2.76%
25,602
-505
-2% -$389K
PXD
9
DELISTED
Pioneer Natural Resource Co.
PXD
$17.3M 2.59%
83,317
+2,326
+3% +$490K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.08T
$16.8M 2.52%
140,574
-1,554
-1% -$179K
INTC icon
11
Intel
INTC
$419B
$16.3M 2.44%
486,575
+14,278
+3% +$448K
AMT icon
12
American Tower
AMT
$80.7B
$15.5M 2.32%
79,830
-997
-1% -$195K
ZBRA icon
13
Zebra Technologies
ZBRA
$13.4B
$13.6M 2.04%
45,963
+1,643
+4% +$461K
AMZN icon
14
Amazon
AMZN
$2.46T
$12.7M 1.91%
97,482
+1,170
+1% +$134K
ADBE icon
15
Adobe
ADBE
$105B
$12.7M 1.9%
25,875
+2,692
+12% +$1.08M
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$12.4M 1.86%
27,978
+11,891
+74% +$4.99M
XOM icon
17
ExxonMobil
XOM
$654B
$12.3M 1.85%
114,878
+8,158
+8% +$890K
TSLA icon
18
Tesla
TSLA
$1.19T
$11.9M 1.79%
45,620
-7,153
-14% -$1.43M
LMT icon
19
Lockheed Martin
LMT
$133B
$11.8M 1.77%
25,589
+52
+0.2% +$24.1K
CTAS icon
20
Cintas
CTAS
$87.4B
$11.8M 1.76%
94,700
-5,404
-5% -$634K
ADP icon
21
Automatic Data Processing
ADP
$112B
$11.1M 1.66%
50,439
-1,284
-2% -$277K
MOAT icon
22
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
$10.9M 1.63%
136,342
+2,517
+2% +$189K
SCHE icon
23
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
$8.99M 1.35%
365,049
-2,640
-0.7% -$64.5K
JPM icon
24
JPMorgan Chase
JPM
$927B
$8.3M 1.24%
57,079
-447
-0.8% -$61.5K
MDT icon
25
Medtronic
MDT
$113B
$8.22M 1.23%
93,356
-5,438
-6% -$468K

Similar funds

Apriem Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Apriem Advisors held 154 positions worth $667M, up 6.7% from $625M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Apriem Advisors's Q2 2023 filing shows 3 new, 48 increased, 56 reduced and 11 closed positions. Its largest new stake was Vanguard Growth ETF: 6,066 shares worth $286K. The largest sale was T. Rowe Price, an estimated $1.49M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Apriem Advisors's largest Q2 2023 buy was Vanguard Growth ETF: 6,066 shares worth $286K.
  • Apriem Advisors added most to Schwab US Large- Cap ETF in Q2 2023, an estimated $6.55M increase.
  • Apriem Advisors's biggest Q2 2023 reduction was T. Rowe Price, cutting an estimated $1.49M.
  • Apriem Advisors fully exited Colgate-Palmolive in Q2 2023, selling an estimated $406K.
  • Apriem Advisors's ten largest holdings make up 50% of its $667M portfolio in Q2 2023.
  • Apriem Advisors opened 3 new positions and closed 11 in Q2 2023.
  • Apriem Advisors's portfolio value rose 6.7% quarter-over-quarter to $667M.

Based on Apriem Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.